Relationship between Serum 25-Hydroxyvitamin D and lower extremity arterial disease in type 2 diabetes mellitus patients and the analysis of the intervention of vitamin D

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Zhou, Wan ^a   Ye, Shan Dong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; ORAL ANTIDIABETIC AGENT; RETINOL BINDING PROTEIN 4; 25-HYDROXYVITAMIN D; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DISEASE ASSESSMENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; LOWER EXTREMITY ARTERIAL DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGED; ALGORITHM; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; DOPPLER ULTRASONOGRAPHY; HYPOGLYCEMIA; LEG; METABOLISM; PATHOLOGY; RISK FACTOR;

AGED; ALGORITHMS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; LEG; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; VITAMIN D;

EID: 84928228536     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/815949     Document Type: Article

References (28)

1. A. J. Hills, J. Shalhoub, A. C. Shepherd, and A. H. Davies, "Peripheral arterial disease," British Journal of Hospital Medicine, vol. 70, no. 10, pp. 560-565, 2009.
2. K. O. Thejaswini, M. S. Roopakala, G. Dayananda, S. P. Chandrakala, and K. M. P. Kumar, "A study of association of Ankle Brachial Index (ABI) and the highly sensitiveC-reactive protein (hsCRP) in Type 2 diabetic patients and in normal subjects," Journal of Clinical and Diagnostic Research, vol. 7, no. 1, pp. 46-50, 2013.
3. Q. Chen, C. Y. Smith, K. R. Bailey, P. W. Wennberg, and I. J. Kullo, "Disease location is associated with survival in patients with peripheral arterial disease," Journal of the American Heart Association, vol. 2, no. 5,Article ID e000304, 2013.
4. L. Mosekilde, "Vitamin D requirement and setting recommendation levels: long-term perspectives," Nutrition Reviews, vol. 66, no. 2, pp. S170-S177, 2008.
5. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., "Evaluation, treatment, and prevention of vitaminDdeficiency: an Endocrine Society clinical practice guideline," Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 12, pp. 1911-1930, 2011.
6. A. Hossein-nezhad, A. Spira, and M. F. Holick, "Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized doubleblind clinical trial," PLoS ONE, vol. 8, no. 3, Article ID e58725, 2013.
7. E. Liu, J. B. Meigs, A. G. Pittas et al., "Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults," Journal of Nutrition, vol. 139, no. 2, pp. 329-334, 2009.
8. S. Kayaniyil, R. Vieth, R. Retnakaran et al., "Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes," Diabetes Care, vol. 33, no. 6, pp. 1379-1381, 2010.
9. S. Makariou, E. N. Liberopoulos, M. Elisaf, and A. Challa, "Novel roles of vitamin D in disease: what is new in 2011" European Journal of Internal Medicine, vol. 22, no. 4, pp. 355-362, 2011.
10. Q. Yang, T. E. Graham, N. Mody et al., "Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes," Nature, vol. 436, no. 7049, pp. 356-362, 2005.
11. S. Kim, J. Lim, S. Kye, and H. Joung, "Association between vitamin D status and metabolic syndrome risk among Korean population: based on the KoreanNationalHealth andNutrition Examination Survey IV-2, 2008," Diabetes Research and Clinical Practice, vol. 96, no. 2, pp. 230-236, 2012.
12. I. Kojima,T. Ninomiya, J. Hata et al., "A lowankle brachial index is associated with an increased risk of cardiovascular disease: the hisayama study," Journal of Atherosclerosis and Thrombosis, vol. 21, no. 9, pp. 966-973, 2014.
13. D. Sacks, C. W. Bakal, P. T. Beatty et al., "Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease: a consensus statement developed by the standards division of the society of cardiovascular& interventional radiology," Journal of Vascular and Interventional Radiology, vol. 13, no. 4, article 353, 2002.
14. R. Jorde, M. Sneve, P. Torjesen, and Y. Figenschau, "No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitaminD3 for 1 year," Journal of Internal Medicine, vol. 267, no. 5, pp. 462-472, 2010.
15. T. E. Graham, Q. Yang, M. Blüher et al., "Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects,"The New England Journal ofMedicine, vol. 354, no. 24, pp. 2552-2563, 2006.
16. A. Cabré, I. Lázaro, J. Girona et al., "Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease inType2diabetes," Journal of InternalMedicine, vol. 262, no. 4, pp. 496-503, 2007.
17. D. Metheniti, S. Sakka, M. Dracopoulou et al., "Decreased circulating 25-(OH) Vitamin D concentrations in obese female children and adolescents: positive associations with Retinol Binding Protein-4 and Neutrophil Gelatinase-associated Lipocalin," Hormones (Athens), vol. 12, no. 3, pp. 397-404, 2013.
18. M. F. McCarty and C. A. Thomas, "PTH excess may promote weight gain by impeding catecholamine-induced lipolysisimplications for the impact of calcium, vitamin D, and alcohol on body weight," Medical Hypotheses, vol. 61, no. 5-6, pp. 535-542, 2003.
19. M. L. Melamed, P. Muntner, E. D. Michos et al., "Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 6, pp. 1179-1185, 2008.
20. A. Fahrleitner-Pammer, A. Obernosterer, E. Pilger et al., "Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease," Osteoporosis International, vol. 16, no. 3, pp. 319-324, 2005.
21. T. W. Dunlop, S. Väisänen, C. Frank, F. Molnár, L. Sinkkonen, andC. Carlberg, "The human peroxisome proliferator-activated receptor gene is a primary target of 1,25-dihydroxyvitamin D3 and its nuclear receptor," Journal of Molecular Biology, vol. 349, no. 2, pp. 248-260, 2005.
22. O. J. de Boer, F. Hirsch, A. C. van der Wal, C. M. van der Loos, P. K. Das, and A. E. Becker, "Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation," Atherosclerosis, vol. 133, no. 2, pp. 227-234, 1997.
23. A. B. Awad, L. Alappat, and M. Valerio, "Vitamin D and metabolic syndrome risk factors: evidence and mechanisms," Critical Reviews in Food Science and Nutrition, vol. 52, no. 2, pp. 103-112, 2012.
24. V. Lee, E. Rekhi, J. Hoh Kam, and G. Jeffery, "Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function," Neurobiology of Aging, vol. 33, no. 10, pp. 2382-2389, 2012.
25. S. Rueda, C. Fernández-Fernández, F. Romero, M. J. Martí?nez de Osaba, and J. Vidal, "Vitamin D, PTH, and the metabolic syndrome in severely obese subjects," Obesity Surgery, vol. 18, no. 2, pp. 151-154, 2008.
26. A. Bellia, C. Garcovich, M. D'Adamo et al., "Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects," Internal and Emergency Medicine, vol. 8, no. 1, pp. 33-40, 2013.
27. A. G. Pittas, B. Dawson-Hughes, T. Li et al., "Vitamin D and calciumintake in relation to type 2 diabetes inwomen," Diabetes Care, vol. 29, no. 3, pp. 650-656, 2006.
28. G. C. Major, F. Alarie, J. Doré, S. Phouttama, and A. Tremblay, "Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations," American Journal of Clinical Nutrition, vol. 85, no. 1, pp. 54-59, 2007.